{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T16:14:14Z","timestamp":1782490454796,"version":"3.54.5"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T00:00:00Z","timestamp":1768608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"DoW\/USU Brain Tissue Repository and Neuropathology Research Program","award":["312516-1.00-66721"],"award-info":[{"award-number":["312516-1.00-66721"]}]},{"name":"US Defense Medical Research and Development Program","award":["DM178018"],"award-info":[{"award-number":["DM178018"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-36208-8","type":"journal-article","created":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T11:44:23Z","timestamp":1768650263000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["\u03b3-Radiation induces region-specific subcellular alterations of amyotrophic lateral sclerosis and frontotemporal dementia markers in swine brain"],"prefix":"10.1038","volume":"16","author":[{"given":"Diego","family":"Iacono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin K.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Perl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina M.","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,17]]},"reference":[{"issue":"2","key":"36208_CR1","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1136\/jnnp-2021-327520","volume":"93","author":"K M\u00fcller","year":"2022","unstructured":"M\u00fcller, K. et al. De Novo mutations in SOD1 are a cause of ALS. J. Neurol. Neurosurg. Psychiatry. 93 (2), 201\u2013206 (2022).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"36208_CR2","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s41598-021-03891-8","volume":"12","author":"M Berdy\u0144ski","year":"2022","unstructured":"Berdy\u0144ski, M. et al. SOD1 mutations associated with amyotrophic lateral sclerosis analysis of variant severity. Sci. Rep. 12 (1), 103 (2022).","journal-title":"Sci. Rep."},{"issue":"5\u20136","key":"36208_CR3","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1080\/21678421.2023.2165947","volume":"24","author":"JD Berry","year":"2023","unstructured":"Berry, J. D. et al. Epidemiology and economic burden of amyotrophic lateral sclerosis in the united states: a literature review. Amyotroph. Lateral Scler. Frontotemporal Degener. 24 (5\u20136), 436\u2013448 (2023).","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener"},{"issue":"4","key":"36208_CR4","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ncl.2015.07.009","volume":"33","author":"B Oskarsson","year":"2015","unstructured":"Oskarsson, B., Horton, D. K. & Mitsumoto, H. Potential environmental factors in amyotrophic lateral sclerosis. Neurol. Clin. 33 (4), 877\u2013888 (2015).","journal-title":"Neurol. Clin."},{"key":"36208_CR5","first-page":"181","volume":"7","author":"C Ingre","year":"2015","unstructured":"Ingre, C., Roos, P. M., Piehl, F., Kamel, F. & Fang, F. Risk factors for amyotrophic lateral sclerosis. Clin. Epidemiol. 7, 181\u2013193 (2015).","journal-title":"Clin. Epidemiol."},{"key":"36208_CR6","doi-asserted-by":"publisher","first-page":"152504","DOI":"10.1016\/j.scitotenv.2021.152504","volume":"817","author":"ME Newell","year":"2022","unstructured":"Newell, M. E., Adhikari, S. & Halden, R. U. Systematic and state-of the science review of the role of environmental factors in amyotrophic lateral sclerosis (ALS) or lou gehrig\u2019s disease. Sci. Total Environ. 817, 152504 (2022).","journal-title":"Sci. Total Environ."},{"key":"36208_CR7","doi-asserted-by":"publisher","first-page":"1108383","DOI":"10.3389\/fneur.2023.1108383","volume":"14","author":"D Saucier","year":"2023","unstructured":"Saucier, D., Registe, P. P. W., B\u00e9langer, M. & O\u2019Connell, C. Urbanization, air pollution, and water pollution: identification of potential environmental risk factors associated with amyotrophic lateral sclerosis using systematic reviews. Front. Neurol. 14, 1108383 (2023).","journal-title":"Front. Neurol."},{"issue":"3\u20134","key":"36208_CR8","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/21678421.2022.2127324","volume":"24","author":"SA Goutman","year":"2023","unstructured":"Goutman, S. A. et al. Occupational history associates with ALS survival and onset segment. Amyotroph. Lateral Scler. Frontotemporal Degener. 24 (3\u20134), 219\u2013229 (2023a).","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener"},{"key":"36208_CR9","doi-asserted-by":"publisher","first-page":"110292","DOI":"10.1016\/j.envres.2020.110292","volume":"192","author":"M Tesauro","year":"2021","unstructured":"Tesauro, M. et al. Metal(loid)s role in the pathogenesis of amyotrophic lateral sclerosis: Environmental, epidemiological, and genetic data. Environ. Res. 192, 110292 (2021).","journal-title":"Environ. Res."},{"issue":"10","key":"36208_CR10","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41582-023-00867-2","volume":"19","author":"SA Goutman","year":"2023","unstructured":"Goutman, S. A., Savelieff, M. G., Jang, D. G., Hur, J. & Feldman, E. L. The amyotrophic lateral sclerosis exposome: recent advances and future directions. Nat. Rev. Neurol. 19 (10), 617\u2013634 (2023b).","journal-title":"Nat. Rev. Neurol."},{"key":"36208_CR11","doi-asserted-by":"publisher","first-page":"106923","DOI":"10.1007\/s00415-024-12644-2","volume":"271","author":"W Jin","year":"2024","unstructured":"Jin, W. et al. Improving prediction models of amyotrophic lateral sclerosis (ALS) using polygenic, pre-existing conditions, and survey-based risk scores in the UK biobank. J. Neurol. 271, 106923\u2013106934 (2024).","journal-title":"J. Neurol."},{"issue":"6","key":"36208_CR12","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1212\/WNL.61.6.750","volume":"61","author":"RW Haley","year":"2003","unstructured":"Haley, R. W. Excess incidence of ALS in young Gulf war veterans. Neurology 61 (6), 750\u2013756 (2003).","journal-title":"Neurology"},{"key":"36208_CR13","doi-asserted-by":"crossref","unstructured":"Horner, R. D. et al. Occurrence of amyotrophic lateral sclerosis among Gulf War veterans. Neurology. 61(6):742-9 Erratum in: Neurology. 61(9):1320 (2003 Nov 11). (2003) Sep 23.","DOI":"10.1212\/01.WNL.0000069922.32557.CA"},{"issue":"1","key":"36208_CR14","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2353\/ajpath.2007.070182","volume":"171","author":"NJ Cairns","year":"2007","unstructured":"Cairns, N. J. et al. TDP-43 in Familial and sporadic frontotemporal Lobar degeneration with ubiquitin inclusions. Am. J. Pathol. 171 (1), 227\u2013240 (2007).","journal-title":"Am. J. Pathol."},{"issue":"7\u20138","key":"36208_CR15","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1080\/21678421.2017.1354996","volume":"18","author":"BS de Vries","year":"2017","unstructured":"de Vries, B. S. et al. A case series of PLS patients with frontotemporal dementia and overview of the literature. Amyotroph. Lateral Scler. Frontotemporal Degener. 18 (7\u20138), 534\u2013548 (2017).","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener"},{"issue":"8","key":"36208_CR16","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1007\/s00415-018-8917-5","volume":"265","author":"S Agarwal","year":"2018","unstructured":"Agarwal, S. et al. Primary lateral sclerosis and the amyotrophic lateral sclerosis-frontotemporal dementia spectrum. J. Neurol. 265 (8), 1819\u20131828 (2018).","journal-title":"J. Neurol."},{"issue":"3\u20134","key":"36208_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/21678421.2016.1267768","volume":"18","author":"MJ Strong","year":"2017","unstructured":"Strong, M. J. et al. Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria. Amyotroph. Lateral Scler. Frontotemporal Degener. 18 (3\u20134), 153\u2013174 (2017).","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener"},{"issue":"4","key":"36208_CR18","doi-asserted-by":"publisher","first-page":"e402","DOI":"10.1212\/WNL.0000000000013123","volume":"98","author":"C Cividini","year":"2022","unstructured":"Cividini, C. et al. Amyotrophic lateral Sclerosis-Frontotemporal dementia: shared and divergent neural correlates across the clinical spectrum. Neurology 98 (4), e402\u2013e415 (2022).","journal-title":"Neurology"},{"issue":"19","key":"36208_CR19","doi-asserted-by":"publisher","first-page":"14647","DOI":"10.3390\/ijms241914647","volume":"24","author":"KA Jellinger","year":"2023","unstructured":"Jellinger, K. A. The spectrum of cognitive dysfunction in amyotrophic lateral sclerosis: an update. Int. J. Mol. Sci. 24 (19), 14647 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"36208_CR20","doi-asserted-by":"publisher","first-page":"838","DOI":"10.3389\/fphys.2019.00838","volume":"10","author":"B Hoffe","year":"2019","unstructured":"Hoffe, B. & Holahan, M. R. The use of pigs as a translational model for studying neurodegenerative diseases. Front. Physiol. 10, 838 (2019).","journal-title":"Front. Physiol."},{"issue":"2","key":"36208_CR21","doi-asserted-by":"publisher","first-page":"100013","DOI":"10.1016\/j.labinv.2022.100013","volume":"103","author":"T Kondo","year":"2023","unstructured":"Kondo, T. et al. A Transgenic pig model with human mutant SOD1 exhibits the early pathology of amyotrophic lateral sclerosis. Lab. Invest. 103 (2), 100013 (2023).","journal-title":"Lab. Invest."},{"issue":"3","key":"36208_CR22","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2203\/dose-response.06-102.Luckey","volume":"4","author":"TD Luckey","year":"2006","unstructured":"Luckey, T. D. Radiation hormesis: the good, the bad, and the ugly. Dose Response. 4 (3), 169\u2013190 (2006).","journal-title":"Dose Response"},{"issue":"10","key":"36208_CR23","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1080\/09553002.2017.1328750","volume":"93","author":"JD Boice Jr","year":"2017","unstructured":"Boice, J. D. Jr The linear nonthreshold (LNT) model as used in radiation protection: an NCRP update. Int. J. Radiat. Biol. 93 (10), 1079\u20131092 (2017).","journal-title":"Int. J. Radiat. Biol."},{"issue":"12","key":"36208_CR24","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.2967\/jnumed.118.217182","volume":"59","author":"M Doss","year":"2018","unstructured":"Doss, M. Are we approaching the end of the linear No-Threshold era? J. Nucl. Med. 59 (12), 1786\u20131793 (2018).","journal-title":"J. Nucl. Med."},{"key":"36208_CR25","doi-asserted-by":"publisher","first-page":"110169","DOI":"10.1016\/j.cellsig.2021.110169","volume":"89","author":"RN Tamaddondoust","year":"2022","unstructured":"Tamaddondoust, R. N., Wang, Y., Jafarnejad, S. M., Graber, T. E. & Alain, T. The highs and lows of ionizing radiation and its effects on protein synthesis. Cell. Signal. 89, 110169 (2022).","journal-title":"Cell. Signal."},{"key":"36208_CR26","doi-asserted-by":"publisher","first-page":"119787","DOI":"10.1016\/j.envpol.2022.119787","volume":"309","author":"EJ Calabrese","year":"2022","unstructured":"Calabrese, E. J., Shamoun, D. Y. & Agathokleous, E. Dose response and risk assessment: evolutionary foundations. Environ. Pollut. 309, 119787 (2022).","journal-title":"Environ. Pollut"},{"issue":"1","key":"36208_CR27","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1038\/s41598-021-81602-z","volume":"11","author":"D Iacono","year":"2021","unstructured":"Iacono, D., Murphy, E. K., Avantsa, S. S., Perl, D. P. & Day, R. M. Reduction of pTau and APP levels in mammalian brain after low-dose radiation. Sci. Rep. 11 (1), 2215 (2021).","journal-title":"Sci. Rep."},{"issue":"1","key":"36208_CR28","doi-asserted-by":"publisher","first-page":"21142","DOI":"10.1038\/s41598-023-48146-w","volume":"13","author":"D Iacono","year":"2023","unstructured":"Iacono, D., Murphy, E. K., Stimpson, C. D., Perl, D. P. & Day, R. M. Low-dose brain radiation: Lowering hyperphosphorylated-tau without increasing DNA damage or oncogenic activation. Sci. Rep. 13 (1), 21142 (2023).","journal-title":"Sci. Rep."},{"issue":"3","key":"36208_CR29","doi-asserted-by":"publisher","first-page":"e0296903","DOI":"10.1371\/journal.pone.0296903","volume":"19","author":"D Iacono","year":"2024","unstructured":"Iacono, D. et al. Proteomic changes in the hippocampus of large mammals after total-body low dose radiation. PLoS One. 19 (3), e0296903 (2024).","journal-title":"PLoS One"},{"key":"36208_CR30","doi-asserted-by":"publisher","first-page":"107024","DOI":"10.1016\/j.parkreldis.2024.107024","volume":"124","author":"D Iacono","year":"2024","unstructured":"Iacono, D., Murphy, E. K., Stimpson, C. D., Perl, D. P. & Day, R. M. Low-dose radiation decreases Lrrk2 levels in the striatum of large mammalian brains: new venues to treat parkinson\u2019s disease? Parkinsonism Relat. Disord. 124, 107024 (2024b).","journal-title":"Parkinsonism Relat. Disord"},{"issue":"6","key":"36208_CR31","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1093\/hmg\/dds526","volume":"22","author":"JG Daigle","year":"2013","unstructured":"Daigle, J. G. et al. RNA-binding ability of FUS regulates neurodegeneration, cytoplasmic mislocalization and incorporation into stress granules associated with FUS carrying ALS-linked mutations. Hum. Mol. Genet. 22 (6), 1193\u20131205 (2013).","journal-title":"Hum. Mol. Genet."},{"issue":"11","key":"36208_CR32","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1002\/1873-3468.12646","volume":"591","author":"H Ederle","year":"2017","unstructured":"Ederle, H. & Dormann, D. TDP-43 and FUS En route from the nucleus to the cytoplasm. FEBS Lett. 591 (11), 1489\u20131507 (2017).","journal-title":"FEBS Lett."},{"issue":"9","key":"36208_CR33","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1093\/brain\/awz217","volume":"142","author":"GE Tyzack","year":"2019","unstructured":"Tyzack, G. E. et al. Widespread FUS mislocalization is a molecular hallmark of amyotrophic lateral sclerosis. Brain 142 (9), 2572\u20132580 (2019).","journal-title":"Brain"},{"key":"36208_CR34","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s40478-015-0235-x","volume":"3","author":"A King","year":"2015","unstructured":"King, A. et al. ALS-FUS pathology revisited: Singleton FUS mutations and an unusual case with both a FUS and TARDBP mutation. Acta Neuropathol. Commun. 3, 62 (2015).","journal-title":"Acta Neuropathol. Commun."},{"issue":"1","key":"36208_CR35","doi-asserted-by":"publisher","first-page":"e542","DOI":"10.1212\/NXG.0000000000000542","volume":"7","author":"J Roggenbuck","year":"2020","unstructured":"Roggenbuck, J. C9orf72 and the care of the patient with ALS or FTD: progress and recommendations after 10 years. Neurol. Genet. 7 (1), e542 (2020).","journal-title":"Neurol. Genet."},{"issue":"3","key":"36208_CR36","doi-asserted-by":"publisher","first-page":"e670","DOI":"10.1212\/NXG.0000000000000670","volume":"8","author":"S Breevoort","year":"2022","unstructured":"Breevoort, S., Gibson, S., Figueroa, K., Bromberg, M. & Pulst, S. Expanding clinical spectrum of C9ORF72-Related disorders and promising therapeutic strategies: A review. Neurol. Genet. 8 (3), e670 (2022).","journal-title":"Neurol. Genet."},{"issue":"4","key":"36208_CR37","doi-asserted-by":"publisher","first-page":"a026757","DOI":"10.1101\/cshperspect.a026757","volume":"8","author":"I Gijselinck","year":"2018","unstructured":"Gijselinck, I., Crut, M. & Van Broeckhoven, C. The genetics of C9orf72 expansions. Cold Spring Harb Perspect. Med. 8 (4), a026757 (2018).","journal-title":"Cold Spring Harb Perspect. Med."},{"issue":"5","key":"36208_CR38","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.neurol.2024.03.008","volume":"180","author":"C Sellier","year":"2024","unstructured":"Sellier, C., Corcia, P., Vourc\u2019h, P. & Dupuis, L. C9ORF72 hexanucleotide repeat expansion: from ALS and FTD to a broader pathogenic role? Rev. Neurol. (Paris). 180 (5), 417\u2013428 (2024).","journal-title":"Rev. Neurol. (Paris)"},{"issue":"3","key":"36208_CR39","doi-asserted-by":"publisher","first-page":"fcad152","DOI":"10.1093\/braincomms\/fcad152","volume":"5","author":"WP Ruf","year":"2023","unstructured":"Ruf, W. P. et al. Spectrum and frequency of genetic variants in sporadic amyotrophic lateral sclerosis. Brain Commun. 5 (3), fcad152 (2023).","journal-title":"Brain Commun."},{"issue":"2","key":"36208_CR40","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","volume":"72","author":"M DeJesus-Hernandez","year":"2011","unstructured":"DeJesus-Hernandez, M. et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72 (2), 245\u2013256 (2011).","journal-title":"Neuron"},{"issue":"7","key":"36208_CR41","doi-asserted-by":"publisher","first-page":"1779e5","DOI":"10.1016\/j.neurobiolaging.2014.01.016","volume":"35","author":"AJ Waite","year":"2014","unstructured":"Waite, A. J. et al. Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion. Neurobiol. Aging. 35 (7), 1779e5\u20131779e13 (2014).","journal-title":"Neurobiol. Aging"},{"issue":"6","key":"36208_CR42","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s00401-013-1199-1","volume":"126","author":"VV Belzil","year":"2013","unstructured":"Belzil, V. V. et al. Reduced C9orf72 gene expression in c9FTD\/ALS is caused by histone trimethylation, an epigenetic event detectable in blood. Acta Neuropathol. 126 (6), 895\u2013905 (2013).","journal-title":"Acta Neuropathol."},{"issue":"4","key":"36208_CR43","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1093\/brain\/awx024","volume":"140","author":"Y Aoki","year":"2017","unstructured":"Aoki, Y. et al. C9orf72 and RAB7L1 regulate vesicle trafficking in amyotrophic lateral sclerosis and frontotemporal dementia. Brain 140 (4), 887\u2013897 (2017).","journal-title":"Brain"},{"issue":"3","key":"36208_CR44","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00401-022-02470-z","volume":"144","author":"CS Bauer","year":"2022","unstructured":"Bauer, C. S. et al. An interaction between synapsin and C9orf72 regulates excitatory synapses and is impaired in ALS\/FTD. Acta Neuropathol. 144 (3), 437\u2013464 (2022).","journal-title":"Acta Neuropathol."},{"issue":"1","key":"36208_CR45","doi-asserted-by":"publisher","first-page":"8420","DOI":"10.1038\/s41467-023-44215-w","volume":"14","author":"ZS Chen","year":"2023","unstructured":"Chen, Z. S. et al. Mutant GGGGCC RNA prevents YY1 from binding to fuzzy promoter which stimulates Wnt\/\u03b2-catenin pathway in C9ALS\/FTD. Nat. Commun. 14 (1), 8420 (2023).","journal-title":"Nat. Commun."},{"issue":"9","key":"36208_CR46","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s41582-018-0047-2","volume":"14","author":"R Balendra","year":"2018","unstructured":"Balendra, R. & Isaacs, A. M. C9orf72-mediated ALS and FTD: multiple pathways to disease. Nat. Rev. Neurol. 14 (9), 544\u2013558 (2018).","journal-title":"Nat. Rev. Neurol."},{"issue":"7567","key":"36208_CR47","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nature14973","volume":"525","author":"K Zhang","year":"2015","unstructured":"Zhang, K. et al. The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature 525 (7567), 56\u201361 (2015).","journal-title":"Nature"},{"issue":"12","key":"36208_CR48","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/nrneurol.2015.219","volume":"11","author":"M van Blitterswijk","year":"2015","unstructured":"van Blitterswijk, M. & Rademakers, R. Neurodegenerative disease: C9orf72 repeats compromise nucleocytoplasmic transport. Nat. Rev. Neurol. 11 (12), 670\u2013672 (2015).","journal-title":"Nat. Rev. Neurol."},{"issue":"15","key":"36208_CR49","doi-asserted-by":"publisher","first-page":"12176","DOI":"10.3390\/ijms241512176","volume":"24","author":"H Yabata","year":"2023","unstructured":"Yabata, H. et al. Nuclear expression of TDP-43 is linked with morphology and ubiquitylation of cytoplasmic aggregates in amyotrophic lateral sclerosis. Int. J. Mol. Sci. 24 (15), 12176 (2023).","journal-title":"Int. J. Mol. Sci."},{"issue":"17","key":"36208_CR50","doi-asserted-by":"publisher","first-page":"9217","DOI":"10.3390\/ijms22179217","volume":"22","author":"MFW Semmelink","year":"2021","unstructured":"Semmelink, M. F. W., Steen, A. & Veenhoff, L. M. Measuring and interpreting nuclear transport in neurodegenerative Disease-The example of C9orf72 ALS. Int. J. Mol. Sci. 22 (17), 9217 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"36208_CR51","doi-asserted-by":"publisher","first-page":"RP89694","DOI":"10.7554\/eLife.89694","volume":"12","author":"H Jafarinia","year":"2024","unstructured":"Jafarinia, H., van der Giessen, E. & Onck, P. R. C9orf72 polypr directly binds to various nuclear transport components. Elife 12, RP89694 (2024).","journal-title":"Elife"},{"issue":"9","key":"36208_CR52","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.1093\/brain\/awad120","volume":"146","author":"SH Van Daele","year":"2023","unstructured":"Van Daele, S. H. et al. Genetic variability in sporadic amyotrophic lateral sclerosis. Brain 146 (9), 3760\u20133769 (2023).","journal-title":"Brain"},{"issue":"3","key":"36208_CR53","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1136\/jmg-2023-109580","volume":"61","author":"AGL Douglas","year":"2024","unstructured":"Douglas, A. G. L. & Baralle, D. Reduced penetrance of gene variants causing amyotrophic lateral sclerosis. J. Med. Genet. 61 (3), 294\u2013297 (2024).","journal-title":"J. Med. Genet."},{"issue":"12","key":"36208_CR54","doi-asserted-by":"publisher","first-page":"a024299","DOI":"10.1101\/cshperspect.a024299","volume":"7","author":"IRA Mackenzie","year":"2017","unstructured":"Mackenzie, I. R. A. & Neumann, M. Fused in sarcoma neuropathology in neurodegenerative disease. Cold Spring Harb Perspect. Med. 7 (12), a024299 (2017).","journal-title":"Cold Spring Harb Perspect. Med."},{"issue":"1","key":"36208_CR55","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41593-023-01496-0","volume":"27","author":"J L\u00f3pez-Erauskin","year":"2024","unstructured":"L\u00f3pez-Erauskin, J. et al. Stathmin-2 loss leads to neurofilament-dependent axonal collapse, driving motor and sensory denervation. Nat. Neurosci. 27 (1), 34\u201347 (2024).","journal-title":"Nat. Neurosci."},{"key":"36208_CR56","doi-asserted-by":"publisher","first-page":"1251551","DOI":"10.3389\/fcell.2023.1251551","volume":"11","author":"S Pickles","year":"2023","unstructured":"Pickles, S. et al. CRISPR interference to evaluate modifiers of C9ORF72-mediated toxicity in FTD. Front. Cell. Dev. Biol. 11, 1251551 (2023).","journal-title":"Front. Cell. Dev. Biol."},{"issue":"1","key":"36208_CR57","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00401-024-02720-2","volume":"147","author":"E Udine","year":"2024","unstructured":"Udine, E. et al. Abundant transcriptomic alterations in the human cerebellum of patients with a C9orf72 repeat expansion. Acta Neuropathol. 147 (1), 73 (2024).","journal-title":"Acta Neuropathol."},{"issue":"7","key":"36208_CR58","doi-asserted-by":"publisher","first-page":"104861","DOI":"10.1016\/j.jbc.2023.104861","volume":"299","author":"EJC Thornburg-Suresh","year":"2023","unstructured":"Thornburg-Suresh, E. J. C., Richardson, J. E. & Summers, D. W. The Stathmin-2 membrane-targeting domain is required for axon protection and regulated degradation by DLK signaling. J. Biol. Chem. 299 (7), 104861 (2023).","journal-title":"J. Biol. Chem."},{"key":"36208_CR59","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s40478-015-0215-1","volume":"3","author":"A Uchino","year":"2015","unstructured":"Uchino, A. et al. Incidence and extent of TDP-43 accumulation in aging human brain. Acta Neuropathol. Commun. 3, 35 (2015).","journal-title":"Acta Neuropathol. Commun."},{"issue":"4","key":"36208_CR60","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1007\/s11357-021-00383-5","volume":"43","author":"RJ Eck","year":"2021","unstructured":"Eck, R. J., Kraemer, B. C. & Liachko, N. F. Regulation of TDP-43 phosphorylation in aging and disease. Geroscience 43 (4), 1605\u20131614 (2021).","journal-title":"Geroscience"},{"issue":"8","key":"36208_CR61","doi-asserted-by":"publisher","first-page":"3843","DOI":"10.3390\/ijms22083843","volume":"22","author":"Y Riku","year":"2021","unstructured":"Riku, Y. et al. Pathway from TDP-43-Related pathology to neuronal dysfunction in amyotrophic lateral sclerosis and frontotemporal Lobar degeneration. Int. J. Mol. Sci. 22 (8), 3843 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"6415","key":"36208_CR62","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/362059a0","volume":"362","author":"DR Rosen","year":"1993","unstructured":"Rosen, D. R. et al. Mutations in Cu\/Zn superoxide dismutase gene are associated with Familial amyotrophic lateral sclerosis. Nature 362 (6415), 59\u201362 (1993).","journal-title":"Nature"},{"issue":"5124","key":"36208_CR63","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1126\/science.8351519","volume":"261","author":"HX Deng","year":"1993","unstructured":"Deng, H. X. et al. Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science 261 (5124), 1047\u20131051 (1993).","journal-title":"Science"},{"issue":"5918","key":"36208_CR64","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1126\/science.1166066","volume":"323","author":"TJ Kwiatkowski","year":"2009","unstructured":"Kwiatkowski, T. J. et al. Mutations in the FUS\/TLS gene on chromosome 16 cause Familial amyotrophic lateral sclerosis. Science 323 (5918), 1205\u20131208 (2009).","journal-title":"Science"},{"issue":"Pt 11","key":"36208_CR65","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1093\/brain\/awp214","volume":"132","author":"M Neumann","year":"2009","unstructured":"Neumann, M. et al. I.R. A new subtype of frontotemporal Lobar degeneration with FUS pathology. Brain 132 (Pt 11), 2922\u20132931 (2009).","journal-title":"Brain"},{"issue":"2","key":"36208_CR66","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41593-018-0293-z","volume":"22","author":"Z Melamed","year":"2019","unstructured":"Melamed, Z. et al. Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. Nat. Neurosci. 22 (2), 180\u2013190 (2019).","journal-title":"Nat. Neurosci."},{"issue":"11","key":"36208_CR67","doi-asserted-by":"publisher","first-page":"6080","DOI":"10.1172\/JCI139741","volume":"130","author":"M Prudencio","year":"2020","unstructured":"Prudencio, M. et al. Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia. J. Clin. Invest. 130 (11), 6080\u20136092 (2020).","journal-title":"J. Clin. Invest."},{"issue":"2","key":"36208_CR68","first-page":"47","volume":"20","author":"K Wakabayashi","year":"2001","unstructured":"Wakabayashi, K. et al. Ubiquitinated neuronal inclusions in the neostriatum in patients with amyotrophic lateral sclerosis with and without dementia\u2013a study of 60 patients 31 to 87 years of age. Clin. Neuropathol. 20 (2), 47\u201352 (2001).","journal-title":"Clin. Neuropathol."},{"issue":"8","key":"36208_CR69","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1093\/jnen\/63.8.801","volume":"63","author":"EH Bigio","year":"2004","unstructured":"Bigio, E. H. et al. Neuronal ubiquitinated intranuclear inclusions in Familial and non-familial frontotemporal dementia of the motor neuron disease type associated with amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 63 (8), 801\u2013811 (2004).","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"5796","key":"36208_CR70","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann, M. et al. Ubiquitinated TDP-43 in frontotemporal Lobar degeneration and amyotrophic lateral sclerosis. Science 314 (5796), 130\u2013133 (2006).","journal-title":"Science"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36208-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36208-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36208-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T22:03:31Z","timestamp":1770761011000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36208-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,17]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["36208"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-36208-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,17]]},"assertion":[{"value":"2 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The opinions expressed herein are those of the authors and not necessarily representative of those of the Uniformed Services University of the Health Sciences (USUHS), the Department of War (DOW), the United States Army, Navy, or Air Force, any other US government agency and Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF), Inc., Bethesda, MD.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest\u00a0<!--Emphasis Type='Bold' removed-->statement"}},{"value":"All animal work was approved by the Institutional Animal Care and Use Committee at the Uniformed Services University (USU, Bethesda, MD, USA) in compliance with the PHS Policy on Humane Care and Use of Laboratory Animals, the NIH Guide for the Care and Use of Laboratory Animals, and all applicable Federal regulations governing the protection of animals in research.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"5627"}}